#diviity

[onedreamcastentertainment]

KRAASU KRAAJUMU DAUGAVAS KRASTOS

pieDaugavas kjegumaa zem hesa. pa tacinjaam, kur ved uz leju un ir strautinjs. strautaa atrodu elljas kraasas tuubinjas, tubinjaam ir nogriezta apaksha, bet tubinjas ir pilnas . tubinjas no metala taas istaas. man ir skaidrs, ka tur pie daugavas kaads ir ieriikojis savu maksas pleneera vietu, un masiivos apjomos glezno Daugavas ainavas., Mans plaans ir apzagt sho makslinieku - aiznest prom visas kraasas un atdot taas Sandijam, kursh pats diezvai naaktu zagt kraasas, kautgan vinjam taas ir vajadziigas. To, ka shii kraasas un pleneera gleznoshanas vieata pie Daugavas vareetu buut pasha Sandija ipashums, es nemaz nepieljauju.

es taas tubinjas velku ara no strauta un lieku papira maisaa, tadaa kaa modes veikalos, baltaa maisaa ar auklas rokturiiti. Ir ari ljoti lielas tuubinjas tadas uz puotru vai diviem litriem. viena taada ir roza kraaasaa. es to visu salieku , maiss ir pilns un jasak domat, kaa to visu pastiept. Es noeeju zemaak, tuvaak daugavai pa staavo krastu. tur atrodu tads kaa paletes, uz kuraam ir daudz kraasu bundzhu, visas atveertas , parklaatas ar melnu pleevi, taka nomaskeetas, kamuflazheetas. es taas aaku cilaat un skatiities, jaa, daudz kraasas. ideja ir izsaukt taksi vai saverveet kaadu mashiinu pa diviiti, lai paliidz aizvest liidz nopelniem bagaatajam tautas maksliniekam Sandijam Kjegumaa.

SHaadi cilajot kraasu bundzhas, peekshnji nogaazes augshpusee paraadaas liela cilveeka teels, viss nosmeereets peleekaa zaljaa kraasaa, no galvas llidz kaajaam nokjeeziits, parsvaraa peleki zaljsh, pleciigs, laikam pat ar uusaam. VInjsh ir nosmeereejies ar kraasaam, mana nojauta ir, ka vinjsh ir tas makslinieks, kursh te sagaazis strautaa atgrieztas elljas kraasu tuubinjas un savaacis vismaz divas paletes ar kraasu bundzhaam, kuras es te cilaju un taisos nospert. Tas pelekais nosmereetais teels mani nosauc par mudaku vai ko tamlidzigu. Vinjsh palaizh valjaa lielu suni vai kautkadu pleesiigu zveeru, bet tam vieniigaa interese ir ielekt uudenii un peldeeties, es tam veel kautko draudziigi uzsaucu. Lielais maakslninieks, nosmeereeetais ar kraasaam no galvas lidz kajam, nak lejaa, vinjam ir liidzi veel kautkaada brigaade, un vinji pie Kjeguma Hesa sliipaas betona malas saak peldeeties. Tam lielajam maksliniekam, kursh krasas savaacis kruumos pie Daugavasun pats nosmereets, pazuud taa peleki zaljaa kraasa uz kjermenja, Vinjsh izraadaas akrobatisks, atleetisks, un daudz peld, ar ieskrejienu lec no betona sliipaas malas iekshaa uudenii ar spariigu atspeerienu un paareejie brigaades biedri (parsvaraa kkadi vechi) to slavee un ovaacijaas paiet viss parejais laiks.

[oneonenightwithphysics]

PAR TO, ka manaa klatbutnee daudzi sak dzit velnu, pat nevainiigas katolju princesiites, kad peec palidziibas fotoshopaa, kas princeseem ir ipashi inteeresejosha programma, taa nomet uz galda diviiti ar piebildi:''še, notriec maukaas".

[faneposting-my-beloved]

Divine Ascension DLC

Lorebook, artbooks, concept art & more!

[cancersfakianakis1]

The Role of Target Therapy in the Treatment of Gastrointestinal Non Colorectal Cancers: Clinical Impact and Cost Consideration.

Related Articles

The Role of Target Therapy in the Treatment of Gastrointestinal Non Colorectal Cancers: Clinical Impact and Cost Consideration.

Curr Cancer Drug Targets. 2017 Feb 08;:

Authors: Berretta M, Di Francia R, De Diviitis C, Nasti G, Canzonieri V, Caraglia M, Facchini G, Tirelli U

Abstract Gastrointestinal (GI) tumors are a leading cause of cancer-related deaths in the world. In fact, gastric cancer (GC) is the third cause of cancer deaths, whereas aesophageal neoplasm is the eighth most common cancer worldwide and its incidence, especially adenocarcinoma type, is continuously increasing. Also Hepatocellular carcinoma, Cholangiocarcinoma and pancreatic cancer represent a very interesting model to multidisciplinary approach and recently new drugs are used in their treatment. Currently, new clinical trials are designed including classic chemotherapy in association with either small molecule inhibitors (i.e. Tyrosine Kinase inhibitors) and/or monoclonal antibody (i.e. anti-EGFR antibody). Moreover, a comphrensive list of new molecules for target therapy is included in this issue. The development of new treatment modalities (multidisciplinary approach) and targeted therapy approaches, have contributed to improve the outcome in these cancer diseases. Our expanding knowledge of the molecular biology of malignancy, the related identification of therapeutically-important targets, and the subsequent development of systemic agents that inhibit critical kinases and pathways, have all contributed to great excitement and progress in cancer treatment.

PMID: 28183250 [PubMed - as supplied by publisher]

http://ift.tt/2kyUuUh

[oneonenightwithphysics]

ne varavalji, a padarilji

chasi s kamnjami

duhi muzhskiji

Roma, kursh centralstacijaa iIiga agraak ir piedaavaajis smarzhas ''Milloner'', no kuraam laipni atteicos, sakot, ka esmu miljardieris, miljonaru smarzhas man neklaajaas shmiceet, vakar jau piedaavaa ''Magical Man'', pirms tam noskaidrojis cik kilometru ir liidz Jeekabpilij. Saku, ka taadas der, man ir diviitis. Roma jau piedaavaa atveert iepakojumu, ko es vinjam neiesaku, jo pec tam jau atpakaljcelja nebuus. Tas prasa, kaa, nebuus atpakaljcelja. Saku, ka liidz Jekabpilij pa diviiti varbuut veel vareetu tikt, bet atpakalj uz Riigu tak arii jaatiek.

Smarzhu kaste jau nonaakusi manaas rokaas, diviitis pie Romas, bet shis prasa bumagu. Nu par diviti vairak nevaru dot. Prasu, vai Roma grib, lai es vinjam uzdaavinu smarzhu kasti? Nu jaa, to gan gribot.

Uzdavinaju tad arii Romam smarzhu kasti, ar burviigu piebildi, ka tagad varees droshi teikt, ka smarzha nav zagta, bet daavinata.